Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.
SCOR SE's Sloan Ratio for the quarter that ended in Dec. 2025 was 0.00%.
As of Dec. 2025, SCOR SE has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.
SCOR SE (XSWX:SCR) Sloan Ratio % Explanation
A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.
If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.
If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.
If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.
As of Dec. 2025, SCOR SE has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.
SCOR SE Sloan Ratio % Related Terms
SCOR SE Sloan Ratio % Historical Data
* Premium members only.
The historical data trend for SCOR SE's Sloan Ratio % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:SCR vs RGA, EG, RNR: Sloan Ratio % Comparison
For the Insurance - Reinsurance subindustry, SCOR SE's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SCOR SE Sloan Ratio % vs Insurance Industry
For the Insurance industry and Financial Services sector, SCOR SE's Sloan Ratio % distribution charts can be found below:
* The bar in red indicates where SCOR SE's Sloan Ratio % falls into.
Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.
SCOR SE's Sloan Ratio for the fiscal year that ended in Dec. 2025 is calculated as
SCOR SE's Net Income for the trailing twelve months (TTM) ended in Dec. 2025 was 0 (Dec. 2024 ) + 0 (Jun. 2025 ) + 202.763 (Sep. 2025 ) + 195.026 (Dec. 2025 ) = CHF398 Mil.
SCOR SE's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was 0 (Dec. 2024 ) + 0 (Jun. 2025 ) + 0 (Sep. 2025 ) + 0 (Dec. 2025 ) = CHF0 Mil.
SCOR SE's Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2025 was 0 (Dec. 2024 ) + 0 (Jun. 2025 ) + 0 (Sep. 2025 ) + 0 (Dec. 2025 ) = CHF0 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SCOR SE (XSWX:SCR) has a Sloan Ratio % of 0.00% as of Dec. 2025. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on SCOR SE and its competitors.
Is SCOR SE's Sloan Ratio % too high?
SCOR SE's current Sloan Ratio % is 0.00%. Overall, SCOR SE has a GF Score™ of 49/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SCOR SE's Sloan Ratio % compare to RGA and EG?
SCOR SE's Sloan Ratio % of 0.00% can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Sloan Ratio % for an Insurance company?
A good Sloan Ratio % depends on the Insurance industry context. However, Sloan Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Sloan Ratio % mean?
A high Sloan Ratio % can signal that a stock is expensive relative to its fundamentals. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on SCOR SE and its competitors. SCOR SE's current Sloan Ratio % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SCOR SE stock overvalued right now?
Based on GuruFocus' analysis, SCOR SE (XSWX:SCR) is currently considered Modestly Overvalued. The stock's GF Value™ is CHF22.66, compared to a current price of CHF28.80 — trading 27.1% above its estimated fair value. The current Sloan Ratio % is 0.00%. SCOR SE's overall GF Score™ is 49/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Sloan Ratio % calculated?
Sloan Ratio % is calculated from a company's financial statements. For SCOR SE (XSWX:SCR), the current Sloan Ratio % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SCOR SE (XSWX:SCR) Overvalued in 2026?
Based on GuruFocus' analysis, SCOR SE stock appears to be overvalued.
The current stock price of CHF28.80 is trading 27.1% above its estimated GF Value™ of CHF22.66.
GuruFocus considers SCOR SE to be Modestly Overvalued.
Key valuation signals for XSWX:SCR:
Sloan Ratio %: 0.00%
GF Value™: CHF22.66 vs. price of CHF28.80 (27.1% above fair value)
No single metric tells the full story. See the XSWX:SCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Scor is the world's sixth-largest reinsurer, selling nonlife and life reinsurance. Scor Global Life insures life, health, and annuities. This means in its co-insurance agreements Scor shares in premiums and claims of life insurance contracts that have been sold by a primary insurer. In its excess of loss agreements, Scor reimburses a primary insurer for claims that are filed above an agreed amount. Scor also sells property and casualty reinsurance in coinsurance and excess of loss. Historically, Scor has been better in specialist lines and not as good in lines where there is a large potential for loss.
49GF Score
Get the complete analysis for XSWX:SCR
Sloan Ratio % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:SCR has been successfully added to your 
